Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per shar
-
Shares outstanding
-
22,457,615
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
588,048
-
Shares change
-
+107,575
-
Total reported value, excl. options
-
$202,288
-
Value change
-
+$35,854
-
Number of buys
-
8
-
Number of sells
-
2
-
Price
-
$0.3440
Institutional Holders of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) as of Q1 2025
As of 31 Mar 2025 Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 588,048 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, Warberg Asset Management LLC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), UBS Group AG, HARBOUR INVESTMENTS, INC., and BANK OF AMERICA CORP /DE/.
This table shows 10 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.